Tests etrasimod in older adults with ulcerative colitis
Tests the oral drug etrasimod in older adults with ulcerative colitis, a bowel disease.
Plain-language title generated from the registry record
Registry title: Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
Key facts
- Where
- Komagane, JapanSee the site
Where in Japan
- Showa Inan General HospitalKomagane, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Showa Inan General Hospital
- Trial code
- NCT07243639
- Record updated
- 21 July 2026
- Original description
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.Read full original descriptionShow less
A Prospective Study on the Efficacy and Safety of a Novel Oral Drug, Etrasimod, in Elderly Patients With Ulcerative Colitis
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.
Inclusion: Patients with active ulcerative colitis.
Exclusion: the presence of acute or chronic renal failure, chronic heart disease, pulmonary infection, liver cirrhosis, colorectal cancer, autoimmune disease, and infectious disease.